Merck Sale Of Orthopedic Assets Will Grant European Autonomy To Biomet
This article was originally published in The Gray Sheet
Executive Summary
Biomet will redouble European sales and marketing efforts after assuming 100% ownership of its joint venture with Merck KGaA, the firm says